Rupert Vessey

Insider Reports History

Entity
Individual
Location
C/O Celgene Corporation, 86 Morris Avenue, Summit, New Jersey
Signature
/s/ Andrew Nick as Attorney-in-Fact for Rupert Vessey pursuant to Power of Attorney previously filed
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rupert Vessey:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BRISTOL MYERS SQUIBB CO EVP & President, Research Common Stock, $0.10 par value 47,751 $2.38 M $49.78 May 3, 2023 Direct
BRISTOL MYERS SQUIBB CO EVP & President, Research Market Share Units 21,442 $1.15 M $53.79 Mar 10, 2023 Direct
BIO-TECHNE Corp Director Common Stock 7,885 $610 K $77.42 Oct 26, 2023 Direct
BRISTOL MYERS SQUIBB CO EVP & President, Research Restricted Stock Units 8,792 $440 K $50.10 Dec 2, 2022 Direct
BRISTOL MYERS SQUIBB CO EVP & President, Research Common Stock, $0.10 par value 656 $32.6 K $49.78 May 3, 2023 BMS Savings and Investment Program
BIO-TECHNE Corp Director Stock Options (Right to Buy) 3,937 Oct 26, 2023 Direct
BRISTOL MYERS SQUIBB CO EVP & President, Research Performance Shares 0 Mar 10, 2023 Direct
BRISTOL MYERS SQUIBB CO EVP & President, Research Option (right to buy) 0 Nov 7, 2022 Direct

Insider Reports Filed by Rupert Vessey

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TECH BIO-TECHNE Corp Oct 26, 2023 2 0 4 Oct 30, 2023 Director
BMY BRISTOL MYERS SQUIBB CO May 3, 2023 1 -3,378,818 4 May 4, 2023 EVP & President, Research
BMY BRISTOL MYERS SQUIBB CO Mar 10, 2023 16 -2,529,704 4 Mar 14, 2023 EVP & President, Research
BMY BRISTOL MYERS SQUIBB CO Dec 2, 2022 3 -364,923 4 Dec 6, 2022 EVP, Research & Early Dev.
BMY BRISTOL MYERS SQUIBB CO Nov 7, 2022 11 -553,852 4 Nov 9, 2022 EVP, Research & Early Dev.
TECH BIO-TECHNE Corp Oct 27, 2022 2 0 4 Oct 31, 2022 Director
BMY BRISTOL MYERS SQUIBB CO Mar 16, 2022 10 -2,466,361 4 Mar 18, 2022 EVP, Research & Early Dev.
BMY BRISTOL MYERS SQUIBB CO Mar 10, 2022 10 -598,743 4 Mar 14, 2022 EVP, Research & Early Dev.
BMY BRISTOL MYERS SQUIBB CO Mar 1, 2022 3 -707,095 4 Mar 3, 2022 EVP, Research & Early Dev.
BMY BRISTOL MYERS SQUIBB CO Feb 4, 2022 3 -85,267 4 Feb 8, 2022 EVP, Research & Early Dev.
BMY BRISTOL MYERS SQUIBB CO Dec 31, 2021 3 -1,436,108 4 Jan 4, 2022 EVP, Research & Early Dev.
BMY BRISTOL MYERS SQUIBB CO Dec 16, 2021 2 -1,196,252 4 Dec 17, 2021 EVP, Research & Early Dev.
BMY BRISTOL MYERS SQUIBB CO Dec 2, 2021 3 -249,234 4 Dec 6, 2021 EVP, Research & Early Dev.
TECH BIO-TECHNE Corp Oct 28, 2021 2 0 4 Nov 1, 2021 Director
BMY BRISTOL MYERS SQUIBB CO Jul 30, 2021 30 -1,952,046 4 Aug 3, 2021 EVP, Research & Early Dev.
BMY BRISTOL MYERS SQUIBB CO May 8, 2021 3 -515,133 4 May 11, 2021 EVP, Research & Early Dev.
BMY BRISTOL MYERS SQUIBB CO May 5, 2021 1 -1,963,802 4 May 7, 2021 EVP, Research & Early Dev.